Highlight transcript below to create clipTranscript: Print | Email Go Click text to jump within videoMon 01 Apr 13 | 02:38 PM ET Johnson & Johnson just won approval for a new diabetes drug, and the stock is at an all-time high today. Anthony Butler, Barclays, offers insight.
Showing posts with label AllTime. Show all posts
Showing posts with label AllTime. Show all posts
Tuesday, July 16, 2013
Johnson & Johnson Hits All-Time High
Highlight transcript below to create clipTranscript: Print | Email Go Click text to jump within videoMon 01 Apr 13 | 02:38 PM ET Johnson & Johnson just won approval for a new diabetes drug, and the stock is at an all-time high today. Anthony Butler, Barclays, offers insight.Thursday, April 18, 2013
POLL: Opposition To Illinois Marriage Equality At All-Time Low

A new Crain’s/Ipsos Illinois poll shows that opposition to marriage equality in the Land of Lincoln is at an all-time low. While 50 percent support the same-sex marriage bill advancing through the state legislature, only 29 percent are committed to opposing it, while another 20 percent don’t know or have mixed feelings. Supporters also support with more intensity (37 percent “strongly” favor passage) than opponents oppose (19 percent “strongly” disagree with the bill). The legislation passed the Illinois Senate on Valentine’s Day, and proponents are cautiously optimistic about passage in the House.
Labels:
AllTime,
Equality,
Illinois,
Marriage,
opposition
Subscribe to:
Posts (Atom)